Telehealth longevity prescriptions
A telehealth platform offering licensed-provider prescriptions across metabolic health (semaglutide, tirzepatide, metformin), hormone health (sermorelin), and energy and recovery (NAD+, MIC+B12), dispensed by mail from FDA-registered US compounding pharmacies on a cash-pay basis.
quality claims we could confirm ourselves, rather than repeat from the vendor's marketing.
Prescription semaglutide, tirzepatide, and metformin for metabolic health; sermorelin (standard and ODT) for hormone health; and NAD+, NAD+ nasal, and MIC+B12 injections for energy and recovery, all gated behind an online clinician assessment.
Every product ReadyRx offers requires a prescription issued after a licensed provider reviews the patient's submitted health information; none of it is an over-the-counter supplement. Compounded medications, including the NAD+ and sermorelin lines, follow a different regulatory pathway than an FDA-approved branded drug, with oversight resting on the compounding pharmacy rather than a large-scale manufacturer. This entry describes the service; it is not a recommendation to use it, and it is not medical advice.
Graded by whether we could confirm it ourselves or are only repeating what the vendor states. A vendor's honesty about its own testing is a different question from what a published trial shows, so this is a separate scale from the evidence grades on our guides.
Stated on the vendor's site as a core service feature. We did not independently confirm the specific pharmacy or pharmacies used, or pull their FDA registration status ourselves.
Where the vendor states thisThis is a specific, checkable-sounding quality claim, more detailed than a generic "lab tested" statement, but we did not obtain or review an actual batch testing certificate ourselves.
Where the vendor states thisMetformin is a well-established diabetes medication with an emerging, genuinely mixed research literature on cognitive and longevity effects in non-diabetic populations; this is an active area of scientific debate (including the ongoing TAME trial framework), not a settled benefit. Presenting it as a stated cognitive-support use is a stronger framing than the current evidence base clearly supports.
Where the vendor states thisGLP-1 medications, sermorelin, and even NAD+ and MIC+B12 injections carry documented side-effect and interaction profiles. A cash-pay telehealth intake is a real medical process, but it is a different depth of evaluation than an in-person physical exam with a doctor who has your full history.
Metformin's potential cognitive and longevity benefits in people without diabetes remain an actively studied, unresolved question in the scientific literature. Marketing copy that states this as a clear benefit is ahead of where the actual research currently sits.
No. Every product requires a prescription issued after an online provider review, spanning GLP-1 weight medications, sermorelin, NAD+, and related compounded therapies. These are prescription medicines, not over-the-counter supplements.
Every fact above traces to one of these pages, published by the vendor itself and checked on September 13, 2026. Vendor policy pages change without notice, so if something here looks out of date, it probably is.
Compare against
Open pricing, public COAs, strict research-only gate
